SEC Form 4 research
| Issuer | Oric Pharmaceuticals, Inc. |
|---|---|
| Tickers | ORIC |
| Reporting owners | 22 |
| Officers and directors | 7 |
| Last public filing | 2026-10-02 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-02 | 2026-10-01 | Heyman Richard A. | S | 3,200 | $12.91 | Not reported |
| 2026-10-02 | 2026-10-01 | Heyman Richard A. | S | 3,500 | $12.91 | Not reported |
| 2026-09-29 | 2026-09-28 | Piscitelli Dominic | S | 13,400 | $13.53 | Not reported |
| 2026-09-25 | 2026-09-24 | Piscitelli Dominic | S | 500 | $13.51 | Not reported |
| 2026-09-25 | 2026-09-24 | Piscitelli Dominic | S | 100 | $13.5 | Not reported |
| 2026-08-28 | 2026-08-26 | Piscitelli Dominic | S | 77,000 | $13.69 | Not reported |
| 2026-07-28 | 2026-07-24 | Heyman Richard A. | S | 6,100 | $12.02 | Not reported |
| 2026-07-28 | 2026-07-24 | Heyman Richard A. | S | 7,000 | $12.02 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.